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Abstract: Strongyloides stercoralis is an intestinal nematode that is able to infect the host tis-
sue and persist asymptomatic for many years through autoinfection. It causes life-threatening 
hyperinfection in immunocompromised hosts. This report describes a rare case of strongyloidi-
asis in a 40-year-old male following renal transplant, which was diagnosed by colonoscopic 
biopsy. The literature on the subject is also reviewed.
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Introduction
Strongyloides stercoralis is a soil-transmitted intestinal nematode that has been estimated 
to infect at least 60 million people, especially in tropical and subtropical regions.1–4 Many 
infected patients are completely asymptomatic and the infection can remain undetected 
for years. The uncomplicated intestinal form of the disease usually produces nonspecific 
abdominal symptoms with or without mild sporadic diarrhea. Strongyloides infection, 
in contrast, has been described in a variety of conditions including those on immu-
nosuppressant therapy, post-transplantation, hematologic malignant disease, human 
immunodeficiency virus, malnutrition, diabetes mellitus, rheumatoid arthritis, chronic 
renal failure, hypogammaglobulinemia, and chronic alcohol consumption.5–18 In these 
patients, hyperinfection can occur, which, if not recognized and treated aggressively, 
can result in mortality rates as high as 87%.1,19 In humans, S. stercoralis infestation 
most commonly involves the upper small intestine and the usual clinical presentation 
is nonspecific and vague and the infestation can mimic several other conditions such 
as inflammatory bowel disease. Given the increasing numbers of immunocompromised 
individuals, physicians caring for these patients should be aware of this potential and 
sometimes fatal complication. This report describes a 40-year-old male who underwent 
renal transplant and developed colonic hyperinfection with S. stercoralis.
Case report
In 2008, a 40-year-old male was diagnosed with end-stage renal disease of unknown 
etiology and was started on regular hemodialysis. During this time he was also found to 
be hypertensive and was treated with antihypertensive medications. In February 2010, 
he underwent renal transplant after induction with antithymoglobulin. Four months after 
the operation, he started to complain of severe nausea, vomiting, and significant loss of 
weight. At the time of presentation, he was maintained on:   tacrolimus 1 mg orally twice 
daily, mycophenolate mofetil 500 mg orally three times daily, prednisolone 5 mg orally 
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once daily, esomeprazole 40 mg orally once daily, bisoprolol 
5 mg orally once daily, methyldopa 500 mg orally three times 
daily, and calcitriol and cotrimoxazole 480 mg orally twice 
daily. His examination was normal apart from a palpable 
transplanted kidney in the right iliac fossa. Investigations 
showed a white blood cell count of 6.19 × 109/L; neutrophils 
5.37 × 109/L (87.1%); eosinophils 2.5 × 109/L (0.15%); hemo-
globin 10.4 g/dL; hematocrit 33.2%, with a mean cell volume 
of 80.1 and a mean cell hemoglobin of 26.2. His platelet count 
was 301 × 109/L, renal panel showed creatinine of 145 µmol/L, 
blood urea nitrogen 6.3 mmol/L, sodium 128 mmol/L, and 
potassium 3.7 mmol/L. He underwent upper gastrointestinal 
endoscopy, which showed mild gastritis, and the biopsy was 
negative for Helicobacter pylori. As there was no improvement 
on proton pump inhibitors and prokinetics, colonoscopy was 
performed. This revealed aphthoid-like ulcers at the rectum 
and rectosigmoid areas. The ascending colon showed mucosal 
segments with granularity, pin-point ulceration with fibrin 
deposits (see Figure 1), and bleeding on touch. The findings 
were suggestive of inflammatory bowel disease. However, the 
biopsy revealed focal nonspecific inflammation, with larva-like 
parasites spotted on rectal biopsy (see Figure 2). Fecal examina-
tion confirmed the presence of a large number of S. stercoralis. 
He was started on a 10-day course of albendazole 400 mg orally 
twice daily. His symptoms subsided and he gradually started 
gaining weight. Fecal examinations 2 and 4 weeks after the 
initiation of therapy were normal.
Discussion
S. stercoralis is an intestinal nematode of humans. Although 
most infected individuals are asymptomatic,19,20 S.   stercoralis 
is capable of causing a fulminant illness that is often fatal 
if not recognized and treated. This is seen in certain condi-
tions associated with a decrease in host immunity, includ-
ing immunosuppressive therapy (particularly the use of 
glucocorticoids), hematological malignancies, bone marrow 
and renal transplants, human T-cell lymphotropic virus 
type 1 infection, human immunodeficiency virus infection, 
  hypogammaglobulinemia, and malnutrition.5–18 Although 
various immunocompromising conditions have been associ-
ated with hyperinfection, steroids and human T-cell lympho-
tropic virus type 1 infection are the most consistent. In these 
conditions S. stercoralis causes hyperinfection.1,19 The patient 
discussed had a S. stercoralis hyperinfection following renal 
transplant. Of interest is that the majority of cases of hyperin-
fection with S. stercoralis that have occurred following organ 
transplant were seen in patients following renal transplant 
and most of these cases seem to have been precipitated by 
increased glucocorticoid doses in response to rejection.8,17 
The authors’ patient did not show signs of rejection, but he 
was on glucocorticoid therapy and this probably contributed 
to the development of superinfection. Given the increasing 
numbers of immunocompromised patients throughout the 
world, this calls for a closer evaluation and observation of 
all conditions under which S. stercoralis infection becomes 
dangerous. This is of paramount importance to physicians 
caring for these patients, as early identification and treatment 
of those at risk is likely to decrease the morbidity and mortal-
ity associated with S. stercoralis superinfection.
S. stercoralis commonly causes gastrointestinal symptoms 
that are nonspecific and easily attributed to other diseases. This 
was the case in the patient discussed, who was complaining of 
nausea and vomiting only; the striking and alarming feature 
was the sudden and significant weight loss. This called for 
further investigation including colonoscopy, which showed 
features suggestive of inflammatory bowel disease. The 
diagnosis of S. stercoralis infection was made on colonic 
biopsy and subsequently on fecal examination. The definitive 
diagnosis of S. stercoralis infection depends on the demon-
stration of larvae in the feces or duodenal fluid. In uncompli-
cated cases, the intestinal worm load is low and larval output 
is minimal. A single fecal examination thus fails to detect 
larvae in up to 70% of cases.21 Repeated fecal examinations 
increase the sensitivity of detection of S. stercoralis infection.22 
Figure  1  Colonoscopic  picture  showing  aphthoid-like  ulcers,  granularity,  and 
­ pin-point­ulceration­with­fibrin­deposits.
Figure 2 Colonic­biopsy­showing­focal­nonspecific­inflammation­with­Strongyloides 
stercoralis larvae.
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In   immunocompromised patients, the autoinfective cycle of 
S. stercoralis can become amplified into a potentially fatal 
hyperinfection syndrome, characterized by increased numbers 
of infective filariform larvae in the feces.
Strongyloidiasis is a curable disease and early diagnosis 
and appropriate therapy with anthelmintics can reduce mor-
bidity and mortality.23–27 Ivermectin, when compared with 
albendazole and thiabendazole, shows similar or better rates 
of larval clearance from feces with similar side effects but is 
much better tolerated and has become the treatment of choice. 
An important point which must be considered is the fact that 
hyperinfections are often complicated by infections caused 
by gut flora that gain access to extra-intestinal sites, presum-
ably through gut ulcers induced by the filariform larvae. Gut 
flora can include Escherichia coli, Klebsiella pneumoniae, 
Proteus mirabilis, Pseudomonas spp, Enterococcus faecalis, 
coagulase-negative staphylococci, Streptococcus bovis, and 
Streptococcus pneumoniae. Patients on immunosuppressive 
therapy may also develop systemic candidemia in addition 
to enteric Gram-negative infections.
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